Utah Statesman | Utah State The healing power of laughter yoga Utah College Newspapers • Mar 12, 2022
Utah Business.com Biotech leader, Known Medicine partners with Duke University to predict drug treatment responses Wasatch Front • Mar 7, 2022
Salt Lake City Tribune See how Salt Lake City aims to boost biotech and lure better-paying jobs Wasatch Front • Mar 2, 2022
Herald Journal | State News Recursion to Participate in Upcoming Investor Conferences Wasatch Front • Mar 2, 2022
Herald Journal | State News PolarityTE Announces Allowance of Fourth U.S. Patent Wasatch Front • Feb 17, 2022
Herald Journal | State News Recursion to Participate in Upcoming Investor Conferences Wasatch Front • Feb 8, 2022
Deseret News | Utah Quinoa. It's tricky to spell, but these BYU researchers think it's an answer to global food security Utah • Jan 23, 2022
Herald Journal | State News PolarityTE Announces U.S. FDA Approval of IND for Pivotal Phase 3 Study of SkinTE to Support Chronic Cutaneous Ulcer Indication Wasatch Front • Jan 18, 2022
Herald Journal | State News Sentrx Animal Care, Inc. Announces Formation of Their Ophthalmology Scientific and Medical Advisory Board Wasatch Front • Jan 11, 2022
Herald Journal | State News PolarityTE Announces Submission of Complete Response to FDA's Clinical Hold Correspondence for SkinTE Investigational New Drug Application Wasatch Front • Dec 20, 2021
Herald Journal | State News SERA PROGNOSTICS ADDED TO NASDAQ BIOTECHNOLOGY INDEX Wasatch Front • Dec 15, 2021
KSL Utah Recursion Pharma scores multibillion-dollar mega deal with Swiss drug titan Wasatch Front • Dec 8, 2021
Herald Journal | State News Recursion Announces Transformational Collaboration with Roche and Genentech in Neuroscience and Oncology, Advancing Novel Medicines to Patients Using Machine Learning... Wasatch Front • Dec 7, 2021
Utah Business.com Recursion and Bayer expand Fibrosis collaboration to include inferential search capabilities Wasatch Front • Dec 6, 2021
Herald Journal | State News Recursion and Bayer Expand Fibrosis Collaboration to Include Inferential Search Capabilities Wasatch Front • Dec 6, 2021
Utah Business.com Recursion enhances leadership team with three senior appointments Wasatch Front • Nov 30, 2021
Herald Journal | State News Recursion Enhances its Leadership Team and Deepens Focus on Neuroscience with Three Senior Appointments Wasatch Front • Nov 30, 2021
Herald Journal | State News Recursion Provides Business Updates and Reports Third Quarter 2021 Financials Wasatch Front • Nov 10, 2021
Herald Journal | State News PolarityTE Reports Third Quarter Financial Results and Provides Business Update Wasatch Front • Nov 10, 2021
Herald Journal | State News Recursion is Granted FDA Fast Track Designation for REC-2282 for the Potential Treatment of NF2-Mutated Meningiomas Wasatch Front • Oct 7, 2021
Herald Journal | State News PolarityTE Provides Update on Investigational New Drug Application Wasatch Front • Oct 7, 2021
Herald Journal | State News Recursion is Granted Orphan Drug Designation for REC-4881 for the Potential Treatment of Familial Adenomatous Polyposis Wasatch Front • Sep 29, 2021
Herald Journal | State News Recursion Reports Second Quarter 2021 Financials and Provides Business Updates Wasatch Front • Aug 13, 2021
Herald Journal | State News Recursion Announces Therapeutics Advisory Board, Chaired by Joseph Miletich, MD, PhD Wasatch Front • Jul 13, 2021